Literature DB >> 33199896

Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer's disease via H2O2- production.

Heejung Chun1,2,3, Hyeonjoo Im3, You Jung Kang4, Yunha Kim3, Jin Hee Shin5, Woojin Won1,6, Jiwoon Lim1, Yeonha Ju1,7,8, Yongmin Mason Park1,7,8, Sunpil Kim1,6, Seung Eun Lee9, Jaekwang Lee2, Junsung Woo2, Yujin Hwang3, Hyesun Cho3,10, Seonmi Jo2,11, Jong-Hyun Park12, Daesoo Kim11, Doo Yeon Kim13, Jeong-Sun Seo10,14, Byoung Joo Gwag5, Young Soo Kim15, Ki Duk Park8,12,16, Bong-Kiun Kaang17, Hansang Cho4,18,19, Hoon Ryu20,21, C Justin Lee22,23,24,25.   

Abstract

Although the pathological contributions of reactive astrocytes have been implicated in Alzheimer's disease (AD), their in vivo functions remain elusive due to the lack of appropriate experimental models and precise molecular mechanisms. Here, we show the importance of astrocytic reactivity on the pathogenesis of AD using GiD, a newly developed animal model of reactive astrocytes, where the reactivity of astrocytes can be manipulated as mild (GiDm) or severe (GiDs). Mechanistically, excessive hydrogen peroxide (H2O2) originated from monoamine oxidase B in severe reactive astrocytes causes glial activation, tauopathy, neuronal death, brain atrophy, cognitive impairment and eventual death, which are significantly prevented by AAD-2004, a potent H2O2 scavenger. These H2O2--induced pathological features of AD in GiDs are consistently recapitulated in a three-dimensional culture AD model, virus-infected APP/PS1 mice and the brains of patients with AD. Our study identifies H2O2 from severe but not mild reactive astrocytes as a key determinant of neurodegeneration in AD.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33199896     DOI: 10.1038/s41593-020-00735-y

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  43 in total

1.  Principles of Astrogliopathology.

Authors:  Alexei Verkhratsky; Baoman Li; Caterina Scuderi; Vladimir Parpura
Journal:  Adv Neurobiol       Date:  2021

2.  Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.

Authors:  Chun Cui; Hui Hong; Yun Shi; Yu Zhou; Chen-Meng Qiao; Wei-Jiang Zhao; Li-Ping Zhao; Jian Wu; Wei Quan; Gu-Yu Niu; Yi-Bo Wu; Chao-Sheng Li; Li Cheng; Yan Hong; Yan-Qin Shen
Journal:  J Neuroimmune Pharmacol       Date:  2022-01-29       Impact factor: 4.147

3.  Astrocyte Activation, but not Microglia, Is Associated with the Experimental Mouse Model of Schizophrenia Induced by Chronic Ketamine.

Authors:  Ying Wei; Li Xiao; Weihao Fan; Jing Zou; Hong Yang; Bo Liu; Yi Ye; Di Wen; Linchuan Liao
Journal:  J Mol Neurosci       Date:  2022-07-08       Impact factor: 2.866

4.  Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson's disease.

Authors:  An-Qi Dong; Ya-Ping Yang; Shu-Min Jiang; Xiao-Yu Yao; Di Qi; Cheng-Jie Mao; Xiao-Yu Cheng; Fen Wang; Li-Fang Hu; Chun-Feng Liu
Journal:  Acta Pharmacol Sin       Date:  2022-07-27       Impact factor: 7.169

5.  Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells.

Authors:  George E Allen; Aaron S Dhanda; Lisa M Julian
Journal:  Methods Mol Biol       Date:  2022

6.  Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation.

Authors:  Sivaprakasam R Saroja; Kirill Gorbachev; Tcw Julia; Alison M Goate; Ana C Pereira
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-15       Impact factor: 12.779

Review 7.  Satellite Glial Cells and Astrocytes, a Comparative Review.

Authors:  Menachem Hanani; Alexei Verkhratsky
Journal:  Neurochem Res       Date:  2021-02-01       Impact factor: 3.996

Review 8.  Peptides Derived from Growth Factors to Treat Alzheimer's Disease.

Authors:  Suzanne Gascon; Jessica Jann; Chloé Langlois-Blais; Mélanie Plourde; Christine Lavoie; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 9.  Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.

Authors:  Tamar Smit; Natasja A C Deshayes; David R Borchelt; Willem Kamphuis; Jinte Middeldorp; Elly M Hol
Journal:  Glia       Date:  2021-02-25       Impact factor: 7.452

10.  Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson's Disease.

Authors:  Heeyoung An; Hyowon Lee; Seulkee Yang; Woojin Won; C Justin Lee; Min-Ho Nam
Journal:  Exp Neurobiol       Date:  2021-06-30       Impact factor: 3.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.